REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q4 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,101 | -13.6% | 141 | -16.6% | 0.01% | -57.9% |
| Q4 2022 | $3,589 | +19.6% | 169 | -10.1% | 0.02% | – |
| Q1 2022 | $3,000 | -25.0% | 188 | -29.1% | 0.00% | – |
| Q4 2021 | $4,000 | -98.6% | 265 | – | 0.00% | -100.0% |
| Q3 2021 | $289,000 | +44.5% | 0 | – | 0.14% | +88.9% |
| Q2 2021 | $200,000 | -92.9% | 0 | -100.0% | 0.07% | +24.1% |
| Q1 2021 | $2,831,000 | +141450.0% | 15 | +36.4% | 0.06% | +2800.0% |
| Q4 2020 | $2,000 | -99.9% | 11 | -21.4% | 0.00% | -50.0% |
| Q1 2020 | $1,336,000 | +1336.6% | 14 | +75.0% | 0.00% | -93.8% |
| Q4 2019 | $93,000 | +481.2% | 8 | -96.1% | 0.06% | +357.1% |
| Q3 2019 | $16,000 | +33.3% | 204 | +50.0% | 0.01% | +40.0% |
| Q2 2019 | $12,000 | – | 136 | +1842.9% | 0.01% | – |
| Q1 2019 | $0 | -100.0% | 7 | -41.7% | 0.00% | -100.0% |
| Q3 2018 | $1,000 | 0.0% | 12 | +20.0% | 0.00% | 0.0% |
| Q2 2018 | $1,000 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |